1094 related articles for article (PubMed ID: 32850977)
1. Molecular Pathogenesis, Immunopathogenesis and Novel Therapeutic Strategy Against COVID-19.
Chatterjee SK; Saha S; Munoz MNM
Front Mol Biosci; 2020; 7():196. PubMed ID: 32850977
[TBL] [Abstract][Full Text] [Related]
2. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
3. Does hereditary angioedema make COVID-19 worse?
Xu Y; Liu S; Zhang Y; Zhi Y
World Allergy Organ J; 2020 Sep; 13(9):100454. PubMed ID: 32834893
[TBL] [Abstract][Full Text] [Related]
4. Ambroxol Hydrochloride Inhibits the Interaction between Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein's Receptor Binding Domain and Recombinant Human ACE2.
Olaleye OA; Kaur M; Onyenaka CC
bioRxiv; 2020 Sep; ():. PubMed ID: 32995775
[TBL] [Abstract][Full Text] [Related]
5. Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor.
Hati S; Bhattacharyya S
ACS Omega; 2020 Jul; 5(26):16292-16298. PubMed ID: 32656452
[TBL] [Abstract][Full Text] [Related]
6. Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment.
Lau SKP; Lau CCY; Chan KH; Li CPY; Chen H; Jin DY; Chan JFW; Woo PCY; Yuen KY
J Gen Virol; 2013 Dec; 94(Pt 12):2679-2690. PubMed ID: 24077366
[TBL] [Abstract][Full Text] [Related]
7. Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology.
Yokota S; Miyamae T; Kuroiwa Y; Nishioka K
J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33671159
[TBL] [Abstract][Full Text] [Related]
8. COVID-19: Targeting Proteases in Viral Invasion and Host Immune Response.
Seth S; Batra J; Srinivasan S
Front Mol Biosci; 2020; 7():215. PubMed ID: 33195400
[TBL] [Abstract][Full Text] [Related]
9. Status of mannose-binding lectin (MBL) and complement system in COVID-19 patients and therapeutic applications of antiviral plant MBLs.
Gupta A; Gupta GS
Mol Cell Biochem; 2021 Aug; 476(8):2917-2942. PubMed ID: 33745077
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology of coronavirus disease 2019 for wound care professionals.
Al-Benna S
Int Wound J; 2020 Dec; 17(6):1935-1940. PubMed ID: 32986928
[TBL] [Abstract][Full Text] [Related]
11. Engineering mesenchymal stromal cells with neutralizing and anti-inflammatory capability against SARS-CoV-2 infection.
Zhang X; Han P; Wang H; Xu Y; Li F; Li M; Fan L; Zhang H; Dai Q; Lin H; Qi X; Liang J; Wang X; Yang X
Mol Ther Methods Clin Dev; 2021 Jun; 21():754-764. PubMed ID: 34007862
[TBL] [Abstract][Full Text] [Related]
12. Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases.
Nayak B; Lal G; Kumar S; Das CJ; Saraya A; Shalimar
Front Cell Infect Microbiol; 2021; 11():753249. PubMed ID: 34760721
[TBL] [Abstract][Full Text] [Related]
13. Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor.
Maurya VK; Kumar S; Prasad AK; Bhatt MLB; Saxena SK
Virusdisease; 2020 Jun; 31(2):179-193. PubMed ID: 32656311
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells.
Suzuki YJ; Nikolaienko SI; Dibrova VA; Dibrova YV; Vasylyk VM; Novikov MY; Shults NV; Gychka SG
bioRxiv; 2020 Oct; ():. PubMed ID: 33052333
[TBL] [Abstract][Full Text] [Related]
15. ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives.
Saponaro F; Rutigliano G; Sestito S; Bandini L; Storti B; Bizzarri R; Zucchi R
Front Mol Biosci; 2020; 7():588618. PubMed ID: 33195436
[TBL] [Abstract][Full Text] [Related]
16. The Mechanisms and Animal Models of SARS-CoV-2 Infection.
Jia W; Wang J; Sun B; Zhou J; Shi Y; Zhou Z
Front Cell Dev Biol; 2021; 9():578825. PubMed ID: 33987176
[TBL] [Abstract][Full Text] [Related]
17. Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients.
Bosch-Barrera J; Martin-Castillo B; Buxó M; Brunet J; Encinar JA; Menendez JA
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32517353
[TBL] [Abstract][Full Text] [Related]
18. Geranium and Lemon Essential Oils and Their Active Compounds Downregulate Angiotensin-Converting Enzyme 2 (ACE2), a SARS-CoV-2 Spike Receptor-Binding Domain, in Epithelial Cells.
Senthil Kumar KJ; Gokila Vani M; Wang CS; Chen CC; Chen YC; Lu LP; Huang CH; Lai CS; Wang SY
Plants (Basel); 2020 Jun; 9(6):. PubMed ID: 32575476
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Immuno-Pathogenesis and Potential for Diverse Vaccines and Therapies: Opportunities and Challenges.
McGill AR; Kahlil R; Dutta R; Green R; Howell M; Mohapatra S; Mohapatra SS
Infect Dis Rep; 2021 Feb; 13(1):102-125. PubMed ID: 33557330
[TBL] [Abstract][Full Text] [Related]
20. Understanding the Host Innate Immune Responses against SARS-CoV-2 Infection and COVID-19 Pathogenesis.
Kang YW; Park S; Lee KJ; Moon D; Kim YM; Lee SW
Immune Netw; 2021 Feb; 21(1):e1. PubMed ID: 33728094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
